retatrutide dose clinical trials Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial retatrutide dosing phase 2 trial

2025 doi: 10.1016/S2213-8587(24)00316-4

Goal: metabolic health improvement without maximum weight loss Some researchers are primarily interested in retatrutide for metabolic health markers: insulin sensitivity, liver fat reduction, lipid profiles, and inflammatory markers

Millions of people want the benefits but face barriers: high costs, prescription requirements, concerns about long-term use , or simply not qualifying medically

Your LMN is valid for 12 months

Also consider your injection timing , diet planning , and overall protocol optimization to maximize results from day one

Prioritize resistance training and protein intake